Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

29
Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department

Transcript of Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Page 1: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Protein Folding of A Biopharmaceutical — hCD83

Lin Zhang

Chemical Engineering

Department

Page 2: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Biopharmaceuticals

Proteins

In use: Insulin tPA

Potential use: Human CD83

Page 3: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Outlines

Backgrounds of hCD83

Preliminary Results and Discussion

Page 4: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Human CD83 (hCD83)

Human CD83 is expressed predominantly on the surface of dendritic cells (DCs)

DCs are the most potent antigen presenting cells of the immune system

Glycoprotein CD83 is one of the best-known maturation markers for human DCs

Page 5: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Backgrounds

hCD83

ArgosDC Bio

Production

Preclinical Trial

Page 6: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Backgrounds

Insulin

Page 7: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Backgrounds

What we are interested in:

Dynamic process of protein folding Protein Aggregation 3D Structure

Page 8: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Backgrounds

FDA Approval

3D Structure

Crystallography

Page 9: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

3D Structure Prediction Flowchart

Target Sequence

Homologous in PDB

Secondary Structure

Comparative Modeling

Tertiary Structure

Conserved Domain

Yes No

ⅡⅠ

Comparison

Page 10: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

Database Searching Protein-Protein Blast

Descriptions

Page 11: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

Page 12: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

1MCP_H

Class: All beta proteins

Fold: Immunoglobulin-like beta-sandwich

sandwich; 7 strands in 2 sheets; greek-key some members of the fold have additional strands

Superfamily: Immunoglobulin (IG)

Family: V set domains (antibody variable domain-like)

1GL4_B

Class: All beta proteins

Fold: Immunoglobulin-like beta-sandwich

sandwich; 7 strands in 2 sheets; greek-key some members of the fold have additional strands

Superfamily: Immunoglobulin (IG)

Family: I set domains

Page 13: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

Protein fold recognition Phyre

1nez_g

Page 14: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

Ⅰ Comparative Modeling

Swiss-Model

RAPTOR

Page 15: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

1MCP_H

(7~121)

Swiss-Model

Page 16: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

Swiss-Model

1a6w_L

Page 17: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Discussion

Common

Page 18: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Discussion

Differences

1MCP_H

1α-helix e f

Page 19: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Discussion

Differences

1a6w_L

b c

2α-helices

e f

Page 20: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

RAPTOR

1a49_a

Page 21: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

1a49_a

1 α-helix: e f : Thr(83)~Ser(87)

Page 22: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

Ⅱ Secondary Structure and Tertiary Structure

Secondary Structure: PHD and Jnet

Tertiary Structure : HMMSTR

Page 23: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

PHD

Page 24: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

Jnet

Page 25: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Discussion

Secondary Structure

PHD: 6 β-strands, no α-helix, not to be globular proteinV(8)~V(10), D(17)~C(20), V(32)~K(36), S(76)~N(81),

T(89)~L(94), V(107)~T(112)

Jnet: 8 β-strands, no α-helixV(8)~C(12), D(15)~T(21), T(31)~K(36), E(43)~T(47)

N(64)~D(68), Y(75)~N(81), T(89)~Q(95), G(104)~T(112)

Page 26: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Preliminary Results

HMMSTR

Page 27: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Discussion

HMMSTR

3 α- helices:

Asp(98)~Asn(102)

Pro(115)~Arg (118)

Lys(119)~Ile(130)

Page 28: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Discussion

Comparison

A. Fold PatternComparative Modeling: distinguished hydrophobic core and hydrophilic side, regular, tight

HMMSTR: irregular, loose pattern, no related motif

Page 29: Protein Folding of A Biopharmaceutical — hCD83 Lin Zhang Chemical Engineering Department.

Discussion

Comparison

B. CompositionComparative Modeling: more beta-strands and loops

as well as hydrogen bonds

HMMSTR: less beta-strands, loops and hydrogen bonds